LeMaitre Vascular Valuation

LMAT Stock  USD 84.82  0.09  0.11%   
At this time, the firm appears to be overvalued. LeMaitre Vascular secures a last-minute Real Value of $76.34 per share. The latest price of the firm is $84.82. Our model forecasts the value of LeMaitre Vascular from reviewing the firm fundamentals such as return on equity of 0.14, and Profit Margin of 0.20 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting LeMaitre Vascular's valuation include:
Price Book
5.6729
Enterprise Value
1.8 B
Enterprise Value Ebitda
26.9571
Price Sales
8.791
Forward PE
37.8788
Overvalued
Today
84.82
Please note that LeMaitre Vascular's price fluctuation is very steady at this time. Calculation of the real value of LeMaitre Vascular is based on 3 months time horizon. Increasing LeMaitre Vascular's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
LeMaitre Vascular's intrinsic value may or may not be the same as its current market price of 84.82, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  84.82 Real  76.34 Target  98.78 Hype  84.82 Naive  86.93
The intrinsic value of LeMaitre Vascular's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence LeMaitre Vascular's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
76.34
Real Value
93.30
Upside
Estimating the potential upside or downside of LeMaitre Vascular helps investors to forecast how LeMaitre stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LeMaitre Vascular more accurately as focusing exclusively on LeMaitre Vascular's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.480.500.52
Details
Hype
Prediction
LowEstimatedHigh
82.7184.8286.93
Details
Potential
Annual Dividend
LowForecastedHigh
0.400.400.40
Details
10 Analysts
Consensus
LowTarget PriceHigh
89.8998.78109.64
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use LeMaitre Vascular's intrinsic value based on its ongoing forecasts of LeMaitre Vascular's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against LeMaitre Vascular's closest peers.

LeMaitre Vascular Cash

18.71 Million

LeMaitre Valuation Trend

LeMaitre Vascular's real value is important for investors to make better decisions and a more accurate overall view of LeMaitre Vascular's financial worth over time. Using both LeMaitre Vascular's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.

LeMaitre Vascular Total Value Analysis

LeMaitre Vascular is now forecasted to have valuation of 1.8 B with market capitalization of 1.93 B, debt of 185.69 M, and cash on hands of 75.68 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the LeMaitre Vascular fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
1.8 B
1.93 B
185.69 M
75.68 M

LeMaitre Vascular Investor Information

About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.23. LeMaitre Vascular last dividend was issued on the 13th of March 2025. Based on the analysis of LeMaitre Vascular's profitability, liquidity, and operating efficiency, LeMaitre Vascular is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in April.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Cash From Operating Activities46.3 M44.1 M
Sufficiently Up
Slightly volatile

LeMaitre Vascular Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. LeMaitre Vascular has an asset utilization ratio of 39.84 percent. This implies that the Company is making $0.4 for each dollar of assets. An increasing asset utilization means that LeMaitre Vascular is more efficient with each dollar of assets it utilizes for everyday operations.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

LeMaitre Vascular Ownership Allocation

LeMaitre Vascular maintains a total of 22.56 Million outstanding shares. The majority of LeMaitre Vascular outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LeMaitre Vascular to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in LeMaitre Vascular. Please pay attention to any change in the institutional holdings of LeMaitre Vascular as this could imply that something significant has changed or is about to change at the company. Also note that almost nine hundred ninety-nine thousand three hundred fourty-six invesors are currently shorting LeMaitre Vascular expressing very little confidence in its future performance.

LeMaitre Vascular Profitability Analysis

The company reported the previous year's revenue of 219.86 M. Net Income was 44.04 M with profit before overhead, payroll, taxes, and interest of 150.9 M.

LeMaitre Vascular Past Distributions to stockholders

About LeMaitre Vascular Valuation

The stock valuation mechanism determines LeMaitre Vascular's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of LeMaitre Vascular based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of LeMaitre Vascular. We calculate exposure to LeMaitre Vascular's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LeMaitre Vascular's related companies.
Last ReportedProjected for Next Year
Gross Profit150.9 M158.4 M
Pretax Profit Margin 0.26  0.27 
Operating Profit Margin 0.24  0.25 
Net Profit Margin 0.20  0.21 
Gross Profit Margin 0.69  0.76 
LeMaitre Vascular's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether LeMaitre Vascular's value is low or high relative to the company's performance and growth projections. Determining the market value of LeMaitre Vascular can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of LeMaitre Vascular represents a small ownership stake in the entity. As a stockholder of LeMaitre, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

LeMaitre Vascular Dividends Analysis For Valuation

At this time, LeMaitre Vascular's Dividends Paid is comparatively stable compared to the past year. Dividend Yield is likely to gain to 0.01 in 2025, whereas Dividend Paid And Capex Coverage Ratio is likely to drop 1.24 in 2025. . At this time, LeMaitre Vascular's Retained Earnings are comparatively stable compared to the past year. Retained Earnings Total Equity is likely to gain to about 118.1 M in 2025, whereas Earnings Yield is likely to drop 0.01 in 2025.
Last ReportedProjected for Next Year
Dividends Paid14.4 M15.1 M
Dividend Yield 0.01  0.01 
Dividend Payout Ratio 0.33  0.46 
Dividend Paid And Capex Coverage Ratio 2.07  1.24 
There are various types of dividends LeMaitre Vascular can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of LeMaitre shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from LeMaitre Vascular directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When LeMaitre pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of LeMaitre Vascular by the value of the dividends paid out.

LeMaitre Vascular Growth Indicators

Investing in growth stocks can be very risky. If the company such as LeMaitre Vascular does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding22.8 M
Quarterly Earnings Growth Y O Y0.3
Forward Price Earnings37.8788

LeMaitre Vascular Current Valuation Indicators

LeMaitre Vascular's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final LeMaitre Vascular's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as LeMaitre Vascular, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use LeMaitre Vascular's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes LeMaitre Vascular's worth.

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.